Free Trial

Kura Oncology (KURA) Insider Trading & Ownership

Kura Oncology logo
$17.45 -0.30 (-1.69%)
(As of 10:53 AM ET)

Kura Oncology (NASDAQ:KURA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.00 M
Get KURA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kura Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KURA Insider Buying and Selling by Quarter

Kura Oncology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/20/2024Teresa Brophy BairInsiderSell2,615$22.15$57,922.25  
1/29/2024Kathleen FordCOOSell1,496$17.80$26,628.80  
1/29/2024Teresa Brophy BairInsiderSell2,053$17.80$36,543.40  
1/29/2024Thomas James DoyleSVPSell2,318$17.80$41,260.40  
1/24/2024Troy Edward WilsonCEOSell91,052$20.23$1,841,981.96  
(Data available from 1/1/2013 forward)

KURA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Kura Oncology includes Anthony Scott Praill, Kathleen Ford, Kirsten Flowers, Laura L Johnson, Saiid Zarrabian, Teresa Brophy Bair, Thomas James Doyle, Thomas Malley, and Troy Edward Wilson. Learn more on insiders at KURA.

5.50% of Kura Oncology stock is owned by insiders. Learn more on KURA's insider holdings.

The following insider purchased KURA shares in the last 24 months: Thomas Malley ($575,000.00).

Insiders have purchased a total of 50,000 KURA shares in the last 24 months for a total of $575,000.00 bought.

The following insiders have sold KURA shares in the last 24 months: Kathleen Ford ($51,922.49), Kirsten Flowers ($26,474.34), Teresa Brophy Bair ($94,465.65), Thomas James Doyle ($62,762.12), and Troy Edward Wilson ($1,841,981.96).

Insiders have sold a total of 104,809 Kura Oncology shares in the last 24 months for a total of $2,077,606.56 sold.

Kura Oncology Key Executives

  • Dr. Troy Edward Wilson J.D. (Age 55)
    Ph.D., Chairman, CEO & President
    Compensation: $1.22M
  • Ms. Kathleen Ford (Age 77)
    Chief Operating Officer
    Compensation: $824.95k
  • Ms. Teresa Brophy Bair Esq. (Age 53)
    J.D., Chief Legal Officer & Corporate Secretary
    Compensation: $705.38k
    1 recent trades
  • Dr. Stephen Dale M.D. (Age 52)
    Chief Medical Officer
    Compensation: $855.3k
  • Mr. Thomas Doyle (Age 53)
    Senior Vice President of Finance & Accounting
  • Mr. Pete De Spain
    Executive Vice President of Investor Relations & Corporate Communications
  • Dr. Roger Bakale Ph.D.
    Senior Vice President of Manufacturing & Supply Chain
  • Ms. Maureen Clancy M.B.A.
    VP and Global Head of Program Leadership & Project Management
  • Dr. Mollie Leoni M.D.
    Executive Vice President of Clinical Development
  • Mr. Brian T. Powl M.B.A. (Age 50)
    M.S., Chief Commercial Officer


This page (NASDAQ:KURA) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners